https://www.selleckchem.com/pr....oducts/muvalaplin.ht
The CS (6.9 ± 1.3 and 6.9 ± 1.5; P = 0.96) and the CCI (3.8 ± 2.0 and 4.1 ± 2.6; P = 0.33) for non-SCD and SCD, respectively, did not differ. The two one-sided t-test analysis for CS (P 0.001) and CCI (P 0.001) demonstrated equivalence. Although larger studies are required to confirm these results, routine SCD use may not be required when implementing ERAS protocols because clinically significant VTE rates were minimal. Although larger studies are required to confirm these results, routine SCD use may not be required when i
Curtir
Comentario
Compartilhar
